Giiant Pharma
Montréal
About Giiant Pharma
Giiant is a preclinical-stage biotech company that, with its proprietary Precision Delivery technology platform, designs gut-restricted, tissue-specific, small molecule, drug therapeutics with various biological targets in gastroenterology. Its lead program GT-2108 is a microbiota-activated PDE4 inhibitor prodrugs, with improved drug tolerability and enhanced therapeutic effect.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $13.4M
- Funding stage: Seed
- Last round: Grant (Dec 2023)
- Website: giiant.com
- Phone: (514) 825-9035
Industries & Categories
Biopharma, Biotechnology, Health Care, Life Science
Social Profiles
Canonical: https://fsome.com/organization/giiant-pharma-100469 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.